ACADIA Pharmaceuticals, Inc. (ACAD)
20.76
+0.29
(+1.42%)
USD |
NASDAQ |
Nov 03, 11:44
ACADIA Pharmaceuticals Price : 20.76 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 20.71 | 20.76 | 20.25 | 20.47 | 1.385M |
| Oct 30, 2026 | 20.88 | 21.01 | 20.49 | 20.59 | 1.137M |
| Oct 29, 2026 | 20.61 | 20.88 | 20.50 | 20.76 | 2.194M |
| Oct 28, 2026 | 20.00 | 20.35 | 20.00 | 20.32 | 1.336M |
| Oct 27, 2026 | 19.58 | 20.29 | 19.51 | 20.17 | 1.332M |
| Oct 26, 2026 | 19.72 | 19.89 | 19.59 | 19.74 | 1.230M |
| Oct 23, 2026 | 20.22 | 20.24 | 19.58 | 19.73 | 1.066M |
| Oct 22, 2026 | 20.30 | 20.50 | 20.12 | 20.31 | 1.229M |
| Oct 21, 2026 | 20.44 | 20.57 | 20.10 | 20.19 | 1.410M |
| Oct 20, 2026 | 20.04 | 20.49 | 19.86 | 20.44 | 1.676M |
| Oct 19, 2026 | 19.33 | 19.84 | 19.11 | 19.80 | 1.299M |
| Oct 16, 2026 | 19.76 | 19.76 | 18.87 | 19.12 | 1.672M |
| Oct 15, 2026 | 19.48 | 19.88 | 19.28 | 19.71 | 1.767M |
| Oct 14, 2026 | 18.60 | 19.28 | 18.49 | 19.25 | 1.643M |
| Oct 13, 2026 | 19.05 | 19.10 | 18.39 | 18.62 | 2.141M |
| Oct 12, 2026 | 19.70 | 19.87 | 19.40 | 19.41 | 1.185M |
| Oct 09, 2026 | 19.60 | 20.05 | 19.58 | 19.78 | 1.470M |
| Oct 08, 2026 | 19.46 | 19.78 | 19.32 | 19.58 | 2.007M |
| Oct 07, 2026 | 19.60 | 19.80 | 19.46 | 19.65 | 1.785M |
| Oct 06, 2026 | 20.16 | 20.36 | 19.67 | 19.74 | 1.666M |
| Oct 05, 2026 | 20.04 | 20.45 | 19.57 | 20.11 | 3.152M |
| Oct 02, 2026 | 20.01 | 20.24 | 19.88 | 19.95 | 2.565M |
| Oct 01, 2026 | 19.95 | 20.19 | 19.59 | 19.89 | 2.732M |
| Sep 30, 2026 | 20.28 | 20.70 | 19.93 | 20.15 | 3.134M |
| Sep 29, 2026 | 20.60 | 20.60 | 20.06 | 20.22 | 2.515M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcutis Biotherapeutics, Inc. | 32.26 |
| Gilead Sciences, Inc. | 170.10 |
| Ionis Pharmaceuticals, Inc. | 40.41 |
| MannKind Corp. | 3.70 |
| Vertex Pharmaceuticals, Inc. | 534.78 |
Price Related Metrics
| PE Ratio | 9.350 |
| PS Ratio | 3.134 |
| PEG Ratio | 0.1399 |
| Price to Book Value | 2.735 |
| Price to Free Cash Flow | 24.50 |
| Earnings Yield | 10.70% |
| Market Cap | 3.573B |
| PEGY Ratio | 0.1399 |
| Operating PE Ratio | 41.32 |
| Normalized PE Ratio | 9.350 |